AI Screens Children for Hidden Eating Disorder With 94 Percent Accuracy

Avoidant/Restrictive Food Intake Disorder, better known as ARFID, has long been the quiet sibling of the eating disorder family. Unlike anorexia nervosa or bulimia, it is not driven by concerns about body shape or weight. Instead, children with ARFID simply refuse or restrict what they eat—for reasons that range from sensory aversions to specific textures and tastes, to a striking lack of interest in food, to outright fear of choking or vomiting. The consequences can be severe: stunted growth, dangerous nutritional deficiencies, weight loss, and dependence on supplements or feeding tubes. Yet because the disorder rarely announces itself in dramatic fashion, and because many clinics lack quick, practical screening tools, it is chronically underdiagnosed. A new study published in the Journal of Eating Disorders suggests that machine learning may finally give clinicians the fast, reliable triage instrument they have been missing.

The research, led by Hakan Öğütlü of University College Dublin together with colleagues at institutions in Türkiye and the United States, set out to build a machine learning-based clinical decision support system, or CDSS, that could automatically classify a child’s ARFID risk. The fuel for the model was the Nine Item Avoidant/Restrictive Food Intake Disorder Screen, or NIAS, a short, validated parent-report questionnaire that captures the core manifestations of the disorder. Rather than requiring lengthy specialist interviews, the NIAS lets parents describe their child’s eating behavior in a handful of items—covering selective eating, low appetite, and fear-based avoidance—making it ideal for busy primary care and pediatric settings where most suspected cases first surface.

The study team analyzed retrospective NIAS-Parent Report data collected from 440 children aged six to twelve years in Türkiye. Using the recommended clinical cut-off scores on the NIAS subscales, each child was categorized as either High ARFID Risk or Low ARFID Risk, effectively creating labeled examples from which a machine learning algorithm could learn. This is the classic supervised learning setup: the model is shown many paired examples of questionnaire responses and known outcomes, and it gradually learns the internal patterns that separate one class from the other. Once trained, it can take a fresh questionnaire and output a risk classification within seconds.

The researchers did not settle for a single algorithm. They tested seven tree-based machine learning methods using fivefold cross-validation, a rigorous technique in which the data is split into five parts, the model is trained on four and evaluated on the fifth, and the process is repeated so that every portion of the dataset serves once as the test set. Cross-validation guards against the most seductive failure mode in machine learning: a model that memorizes its training data instead of learning generalizable rules. Among the algorithms trialed, Extra Trees and CATBoosting emerged as the strongest performers, each achieving an overall accuracy of 96 percent—a striking figure given the brevity of the nine-item instrument they were working from.

High accuracy, however, was not the only design goal. In clinical medicine, a model that cannot explain itself is a hard sell. A psychiatrist or pediatrician who is told that a child is at high risk will reasonably ask why, and a black-box neural network cannot answer. For that reason, the team deliberately optimized a simpler Decision Tree model, a method whose internal logic can be traced branch by branch. The final Decision Tree achieved 94.1 percent overall classification accuracy—only marginally below the ensemble methods—while requiring just one to four decision points, typically two or three, to classify a child. In other words, a clinician can walk the model’s reasoning in a few short steps, checking exactly which questionnaire answers tipped the balance toward high risk.

The feature importance analysis, which quantifies how much each input variable contributes to the model’s predictions, delivered perhaps the most clinically interesting findings. Three items dominated: NIAS7, which measures fear-based food avoidance; NIAS4, which captures low intake and lack of appetite; and NIAS2, which reflects selective eating. These map neatly onto the three diagnostic presentations of ARFID recognized in psychiatric classification—avoidance related to aversive consequences, apparent lack of interest in eating, and restriction driven by sensory selectivity. The machine learning model, in effect, rediscovered the disorder’s clinical structure from raw questionnaire data alone, providing a form of computational validation that the NIAS is measuring what it claims to measure.

The authors describe their system as a prototype, and they are appropriately measured about its limitations. The data came from a single country and a single age band, six to twelve years, and the risk labels were derived from NIAS cut-off scores rather than from full structured diagnostic interviews, the gold standard for confirming ARFID. External validity—performance on completely new populations collected by different teams in different settings—remains unproven. The authors state explicitly that further studies are needed to establish the model’s real-world clinical applicability, and the retrospective design means the system has not yet faced the messiness of a live clinic, where questionnaires arrive incomplete and comorbid conditions blur the picture.

Still, the direction of travel is clear and the clinical logic compelling. ARFID often hides in plain sight: the picky toddler who never grows out of it, the school-age child whose diet narrows to five beige foods, the adolescent whose weight quietly slides down the growth chart. Parents frequently sense that something is wrong long before a professional does, and a rapid, automated screen that converts their observations into an evidence-based risk estimate could shorten the path from concern to assessment. In primary care, where appointment times are measured in minutes and eating disorder expertise is scarce, a CDSS that flags high-risk children in seconds could shift the bottleneck from detection to treatment—the far better place for it to sit.

There is also a broader lesson in the study’s engineering choices. The field of medical artificial intelligence is often dominated by a race for ever-larger models and ever-higher accuracy figures, yet this work argues for a different set of values: interpretability, simplicity, and fit to the clinical workflow. A model that sacrifices two percentage points of accuracy in exchange for decisions a human can inspect in three steps may save more children than an inscrutable black box that clinicians quietly ignore. By pairing a validated nine-item screen with a transparent tree-based classifier, the researchers have built something that could plausibly be embedded in electronic health records and used by nurses, family physicians, and school health services—not just specialist eating disorder centers.

The team, which also includes Azad Azaf, Meryem Kaşak, Uğur Doğan, Hana F. Zickgraf, and Mehmet Hakan Türkçapar, received no external funding for the work and reports no competing interests. If subsequent validation studies confirm the prototype’s performance in diverse populations and real clinical environments, the fusion of a humble paper questionnaire with machine learning could become a template for screening other underrecognized pediatric conditions. For now, the message to clinicians and parents alike is one of cautious optimism: the data patterns that betray ARFID in a child’s relationship with food are real, consistent, and—thanks to a few well-chosen questions and a simple algorithm—now machine-readable.

Subject of Research: A machine learning-based clinical decision support system for screening ARFID risk in children using the Nine Item ARFID Screen (NIAS)

Article Title: A machine learning-based clinical decision support system developed using the nine item avoidant/restrictive food intake disorder screen (NIAS)

Article References: A machine learning-based clinical decision support system developed using the nine item avoidant/restrictive food intake disorder screen (NIAS). (n.d.). https://doi.org/10.1186/s40337-026-01774-9

Image Credits: AI Generated

DOI: 10.1186/s40337-026-01774-9

Keywords: ARFID, eating disorders, machine learning, NIAS, clinical decision support system, children, decision trees, screening, Extra Trees, CATBoosting, pediatrics, feature importance